Literature DB >> 34286443

CCL24 Signaling in the Tumor Microenvironment.

Sung-Jig Lim1.   

Abstract

Chemokines with their network play an important role in cancer growth, metastasis, and host-tumor interactions. Of many chemokines, C-C motif chemokine ligand 24 (CCL24) has been shown to contribute to tumorigenesis as well as inflammatory diseases like asthma, allergies, and eosinophilic esophagitis. CCL24 is expressed in some tumor cells such as colon cancer, hepatocellular carcinoma, and cutaneous T cell lymphoma. CCL24 can be used as a potential biomarker in several cancers including colon cancer, non-small cell cancer, and nasopharyngeal carcinoma as the plasma level of CCL24 is increased. The various functions of CCL24 contribute to the biology of cancer by M2 macrophage polarization, angiogenesis, invasion and migration, and recruitment of eosinophils.
© 2021. The Author(s), under exclusive license to Springer Nature Switzerland AG.

Entities:  

Keywords:  CCL24; Cancer; Eosinophils; Immunotherapy; Tumor microenvironment

Year:  2021        PMID: 34286443     DOI: 10.1007/978-3-030-62658-7_7

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  61 in total

Review 1.  International union of pharmacology. XXII. Nomenclature for chemokine receptors.

Authors:  P M Murphy; M Baggiolini; I F Charo; C A Hébert; R Horuk; K Matsushima; L H Miller; J J Oppenheim; C A Power
Journal:  Pharmacol Rev       Date:  2000-03       Impact factor: 25.468

Review 2.  Chemokines: a new classification system and their role in immunity.

Authors:  A Zlotnik; O Yoshie
Journal:  Immunity       Date:  2000-02       Impact factor: 31.745

Review 3.  The biology of chemokines and their receptors.

Authors:  D Rossi; A Zlotnik
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

Review 4.  The chemokine system: redundancy for robust outputs.

Authors:  A Mantovani
Journal:  Immunol Today       Date:  1999-06

Review 5.  Cancer and the chemokine network.

Authors:  Fran Balkwill
Journal:  Nat Rev Cancer       Date:  2004-07       Impact factor: 60.716

Review 6.  Chemokines and their receptors: drug targets in immunity and inflammation.

Authors:  Antonella Viola; Andrew D Luster
Journal:  Annu Rev Pharmacol Toxicol       Date:  2008       Impact factor: 13.820

Review 7.  Hallmarks of cancer: interactions with the tumor stroma.

Authors:  Kristian Pietras; Arne Ostman
Journal:  Exp Cell Res       Date:  2010-03-06       Impact factor: 3.905

Review 8.  Eotaxins and CCR3 receptor in inflammatory and allergic skin diseases: therapeutical implications.

Authors:  Paolo Amerio; Alessandra Frezzolini; Claudio Feliciani; Roberto Verdolini; Patrizia Teofoli; Ornella De Pità; Pietro Puddu
Journal:  Curr Drug Targets Inflamm Allergy       Date:  2003-03

Review 9.  Chemokine receptors in cancer metastasis and cancer cell-derived chemokines in host immune response.

Authors:  Keiichi Koizumi; Shozo Hojo; Takuya Akashi; Kazuo Yasumoto; Ikuo Saiki
Journal:  Cancer Sci       Date:  2007-11       Impact factor: 6.716

Review 10.  Normalizing tumor microenvironment to treat cancer: bench to bedside to biomarkers.

Authors:  Rakesh K Jain
Journal:  J Clin Oncol       Date:  2013-05-13       Impact factor: 44.544

View more
  2 in total

Review 1.  Advances in Research on the Effects and Mechanisms of Chemokines and Their Receptors in Cancer.

Authors:  Jing Xu; Jing-Quan Li; Qi-Lei Chen; Elena A Shestakova; Vsevolod A Misyurin; Vadim S Pokrovsky; Elena M Tchevkina; Hu-Biao Chen; Hang Song; Jian-Ye Zhang
Journal:  Front Pharmacol       Date:  2022-06-13       Impact factor: 5.988

2.  Systemic Evaluation of the Effect of Diabetes Mellitus on Breast Cancer in a Mouse Model.

Authors:  Nana Wei; Jinmiao Lu; Zhibing Lin; Xiaoyu Wang; Mengmeng Cai; Shengyao Jiang; Xiaoyu Chen; Shilan Zhu; Dong Zhang; Li Cui
Journal:  Front Oncol       Date:  2022-04-29       Impact factor: 5.738

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.